<?xml version="1.0" encoding="UTF-8"?> 
		<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/">
		  <channel>
		    <image>
			<title>patentstorm.us</title>
			<width>258</width>
			<height>85</height>
			<link>http://www.patentstorm.us/</link>
			<url>http://www.patentstorm.us/images/logo.gif</url>
			</image>		

		    <title>PatentStorm -> Patents -> Organic compounds -- part of the class 532-570 series</title>
		    <link>http://www.patentstorm.us/rss/class/patents/rss-540.xml</link>
		    <description>Recent patents filings in USPTO Class 540 Organic compounds -- part of the class 532-570 series.</description>
		    <pubDate>Tue, 7 Feb 2012 16:02:32</pubDate>
		    <managingEditor>patents@patentstorm.us</managingEditor>
		    <language>en</language><item>
			         <title><![CDATA[Optically active quaternary ammonium salt having axial asymmetry, and method for producing alpha-amino acid and derivative thereof by using the same]]></title>
			         <link>http://www.patentstorm.us/patents/8110680/description.html</link>
			         <description><![CDATA[<ul><li><strong>Patent Number:</strong> &nbsp;8110680</li><li><strong>Publication Date:</strong> &nbsp;2012-02-07</li><li><strong>Inventors:</strong> &nbsp;Yamamoto, Kenichiro; Maruoka, Keiji; Nishimoto, Yukifumi</li></ul>
<p>The present invention discloses an optically active quarternary ammonium salt having axial asymmetry and a method for producing an α-amino acid and a derivative thereof using the same. The optically active quarternary ammonium salt having axial asymmetry of the present invention is a chiral phase-transfer catalyst that has a simple structure and that can be produced in a smaller number of process steps. The compound of the present invention is very useful as a phase-transfer catalyst in ...<br /> 		
			         		]]></description>
			         
			         <guid isPermaLink="false">8110680</guid>
			
			      </item>
<item>
			         <title><![CDATA[Nanofilm and membrane compositions]]></title>
			         <link>http://www.patentstorm.us/patents/8110679/description.html</link>
			         <description><![CDATA[<ul><li><strong>Patent Number:</strong> &nbsp;8110679</li><li><strong>Publication Date:</strong> &nbsp;2012-02-07</li><li><strong>Inventors:</strong> &nbsp;Edelstein, Martin S.; Bivin, Donald B.; Merrill, Grant; Joshi, Serena; Micklatcher, Mark; Karpishin, Timothy B.; Smith, Thomas H.; Kriesel, Joshua W.; Whiteford, Jeffery A.; Jonas, Robert T.</li></ul>
<p>Nanofilms useful for filtration are prepared from oriented amphiphilic molecules and oriented macrocyclic modules. The amphiphilic species may be oriented on an interface or surface. The nanofilm may be prepared by depositing or attaching an oriented layer to a substrate. A nanofilm may also be prepared by coupling the oriented macrocyclic modules to provide a ...<br /> 		
			         		]]></description>
			         
			         <guid isPermaLink="false">8110679</guid>
			
			      </item>
<item>
			         <title><![CDATA[Antibiotic-bound poly(caprolactone) polymer]]></title>
			         <link>http://www.patentstorm.us/patents/8110678/description.html</link>
			         <description><![CDATA[<ul><li><strong>Patent Number:</strong> &nbsp;8110678</li><li><strong>Publication Date:</strong> &nbsp;2012-02-07</li><li><strong>Inventors:</strong> &nbsp;Leslie, Michelle; Turos, Edward</li></ul>
<p>This invention is the design and synthesis of a caprolactone monomer which bears a pendant protected carboxyl group. This monomer has been copolymerized with caprolactone in varying ratios. After polymerization, the protecting group can be removed and an antibiotic can be attached as a new pendant group. The bioactivity of the antibiotic-bound poly(caprolactone) polymer is ...<br /> 		
			         		]]></description>
			         
			         <guid isPermaLink="false">8110678</guid>
			
			      </item>
<item>
			         <title><![CDATA[Process for preparation of triazol-benzodiazepine derivatives]]></title>
			         <link>http://www.patentstorm.us/patents/8106189/description.html</link>
			         <description><![CDATA[<ul><li><strong>Patent Number:</strong> &nbsp;8106189</li><li><strong>Publication Date:</strong> &nbsp;2012-01-31</li><li><strong>Inventors:</strong> &nbsp;Naik, Anil M.; Sawant, Shrikant D.; Kavishwar, Girish A.; Kavishwar, Smita G.</li></ul>
<p>An improved process for preparation of triazol-benzodiazepine derivatives, such as alprazolam, triazolam, brotizolam and etizolam, is presented. The process comprises a cyclization reaction of compound Formula B in toluene with catalytic amount of p-toluene sulphonic acid to obtain the triazol-benzodiazepine derivative of Formula C:</p>
<p><chemistry>

</chemistry>
<br></br>
wherein R is,
</p>
<p><chemistry>

</chemistry>
<br></br>
and X is hydrogen or ...<br /> 		
			         		]]></description>
			         
			         <guid isPermaLink="false">8106189</guid>
			
			      </item>
<item>
			         <title><![CDATA[Process for preparing olanzapine form I]]></title>
			         <link>http://www.patentstorm.us/patents/8106188/description.html</link>
			         <description><![CDATA[<ul><li><strong>Patent Number:</strong> &nbsp;8106188</li><li><strong>Publication Date:</strong> &nbsp;2012-01-31</li><li><strong>Inventors:</strong> &nbsp;Meenakshisunderam, Sivakumaran; Ray, Uttam Kumar; Pathuri, Sreenivasa Rao</li></ul>
<p>An improved for preparing Olanzapine Form I of Formula 1 in the presence of one solvent or a mixture of ...<br /> 		
			         		]]></description>
			         
			         <guid isPermaLink="false">8106188</guid>
			
			      </item>
<item>
			         <title><![CDATA[Process for the preparation of a macrocycle]]></title>
			         <link>http://www.patentstorm.us/patents/8106187/description.html</link>
			         <description><![CDATA[<ul><li><strong>Patent Number:</strong> &nbsp;8106187</li><li><strong>Publication Date:</strong> &nbsp;2012-01-31</li><li><strong>Inventors:</strong> &nbsp;Stahr, Helmut; Scalone, Michelangelo</li></ul>
<p>The present invention relates to a new process for the preparation of macrocyclic HCV protease inhibitor compounds of the formula</p>
<p><chemistry>

</chemistry>
<br></br>
wherein R<sup>1 </sup>is an amino protecting group and X is halogen by way of a ring closing metathesis ...<br /> 		
			         		]]></description>
			         
			         <guid isPermaLink="false">8106187</guid>
			
			      </item>
<item>
			         <title><![CDATA[Transition metal phosphine complex, method for producing same, and anticancer agent containing transition metal phospine complex]]></title>
			         <link>http://www.patentstorm.us/patents/8106186/description.html</link>
			         <description><![CDATA[<ul><li><strong>Patent Number:</strong> &nbsp;8106186</li><li><strong>Publication Date:</strong> &nbsp;2012-01-31</li><li><strong>Inventors:</strong> &nbsp;Ohto, Keisuke; Oohara, Nobuhiko; Kaneda, Yoshirou; Kodama, Hiroaki; Nakatsui, Kazuhiro</li></ul>
<p>There is provided a novel transition metal phosphine complex having excellent anticancer activity. The transition metal phosphine complex is represented by general formula (1):</p>
<p><chemistry>

</chemistry>
<br></br>
(wherein R<sup>1</sup>s and R<sup>3</sup>s each represent an alkyl group, a cycloalkyl group, an aryl group, an aralkyl group, a pyridyl group, or a pyrimidyl group; R<sup>2</sup>s and R<sup>4</sup>s each represent an alkyl group or a cycloalkyl group, provided that each ...<br /> 		
			         		]]></description>
			         
			         <guid isPermaLink="false">8106186</guid>
			
			      </item>
<item>
			         <title><![CDATA[Fluorinated catharanthine derivatives, their preparation and their utilisation as dimeric alkaloid precursors]]></title>
			         <link>http://www.patentstorm.us/patents/8101748/description.html</link>
			         <description><![CDATA[<ul><li><strong>Patent Number:</strong> &nbsp;8101748</li><li><strong>Publication Date:</strong> &nbsp;2012-01-24</li><li><strong>Inventors:</strong> &nbsp;Rousseau, Bernard; Comesse, Sébastien; Moisan, Lionel; Giovanelli, Emerson; Doris, Eric; Hellier, Paul</li></ul>
<p>The fluorinated derivatives of catharanthine according to the invention respond to the general formula I:</p>
<p><chemistry>

</chemistry>
<br></br>
in which:
<ul>
    <li>
    <ul>
        <li>the dotted line expresses the possibility of the presence of a double bond when the substitution —X is absent or else a single bond when —X designates a substitution for a group:
        <ul>
            <li>H,</li>
            <li>OR,</li>
            <li>NR′R″,</li>
            <li>SR, ...<br /> 		
			         		]]></description>
			         
			         <guid isPermaLink="false">8101748</guid>
			
			      </item>
<item>
			         <title><![CDATA[Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid]]></title>
			         <link>http://www.patentstorm.us/patents/8101747/description.html</link>
			         <description><![CDATA[<ul><li><strong>Patent Number:</strong> &nbsp;8101747</li><li><strong>Publication Date:</strong> &nbsp;2012-01-24</li><li><strong>Inventors:</strong> &nbsp;Dessinges, Aimee; Serkiz, Bernard; Peglion, Jean-Louis</li></ul>
<p>Process for the synthesis of ivabradine of formula (I):</p>
<p><chemistry>

</chemistry>
<br></br>
and addition salts thereof with a pharmaceutically acceptable ...<br /> 		
			         		]]></description>
			         
			         <guid isPermaLink="false">8101747</guid>
			
			      </item>
<item>
			         <title><![CDATA[High stability polyionic liquid salts]]></title>
			         <link>http://www.patentstorm.us/patents/8097721/description.html</link>
			         <description><![CDATA[<ul><li><strong>Patent Number:</strong> &nbsp;8097721</li><li><strong>Publication Date:</strong> &nbsp;2012-01-17</li><li><strong>Inventors:</strong> &nbsp;Huang, Junmin; Armstrong, Daniel W.</li></ul>
<p>Polyionic liquid salts are provided comprising polycationic or polyanionic molecules. Further provided are solvents comprising one or more polyionic liquid salts, and the use of such polyionic liquid salts as stationary phases in gas chromatography, and as a reagent in electrospray ionization-mass spectrometry ...<br /> 		
			         		]]></description>
			         
			         <guid isPermaLink="false">8097721</guid>
			
			      </item>
<item>
			         <title><![CDATA[Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid]]></title>
			         <link>http://www.patentstorm.us/patents/8097720/description.html</link>
			         <description><![CDATA[<ul><li><strong>Patent Number:</strong> &nbsp;8097720</li><li><strong>Publication Date:</strong> &nbsp;2012-01-17</li><li><strong>Inventors:</strong> &nbsp;Dessinges, Aimee; Serkiz, Bernard; Lecouve, Jean-Pierre; Peglion, Jean-Louis; Lerestif, Jean-Michel</li></ul>
<p>Process for the synthesis of ivabradine of formula (I):</p>
<p><chemistry>

</chemistry>
<br></br>
and addition salts thereof with a pharmaceutically acceptable ...<br /> 		
			         		]]></description>
			         
			         <guid isPermaLink="false">8097720</guid>
			
			      </item>
<item>
			         <title><![CDATA[Meropenem intermediate in novel crystalline form and a method of manufacture of meropenem]]></title>
			         <link>http://www.patentstorm.us/patents/8097719/description.html</link>
			         <description><![CDATA[<ul><li><strong>Patent Number:</strong> &nbsp;8097719</li><li><strong>Publication Date:</strong> &nbsp;2012-01-17</li><li><strong>Inventors:</strong> &nbsp;Khemka, Ashwin A.; Shejul, Pravin B.; Vyavahare, Amol V.; Pandey, Dhirendra Kumar; Shete, Sachin N.; Jadhav, Hanumant K.; Kadam, Nitn H.</li></ul>
<p>The present invention relates to novel crystalline form of (4-Nitrobenzyl (4R,5S,6S)-(3-{(3S,5S)-5-[(dimethylamino)carbonyl]-1-[(4-nitrophenoxy)carbonxyl]pyrrolidin-3-yl}thio-6-[(1R)-1-hydorxyehtyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0].hept-2-ene-2-carboxylate) of compound Formula I as well as an improved process for the preparation of meropenem trihydrate of compound Formula II</p>
<p><chemistry>

</chemistry>
<br></br>
wherein, PNB represent P-nitro benzyl group and PNZ represent ...<br /> 		
			         		]]></description>
			         
			         <guid isPermaLink="false">8097719</guid>
			
			      </item>
</channel>
		</rss>
